Role of the CCL2‐CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting
出版年份 2021 全文链接
标题
Role of the CCL2‐CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting
作者
关键词
-
出版物
CELL PROLIFERATION
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2021-09-01
DOI
10.1111/cpr.13115
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Role of CCL2/CCR2 axis in the immunopathogenesis of rheumatoid arthritis: Latest evidence and therapeutic approaches
- (2021) Fatemeh Moadab et al. LIFE SCIENCES
- Phase I dose‐escalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer
- (2020) Takaaki Masuda et al. CANCER SCIENCE
- CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis
- (2020) Hui Yang et al. Molecular Cancer
- Sex-specific adipose tissue imprinting of regulatory T cells
- (2020) Ajithkumar Vasanthakumar et al. NATURE
- Neoadjuvant checkpoint blockade for cancer immunotherapy
- (2020) Suzanne L. Topalian et al. SCIENCE
- Chemokines and their Receptors: Multifaceted Roles in Cancer Progression and Potential Value as Cancer Prognostic Markers
- (2020) Ha Thi Thu Do et al. Cancers
- Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer
- (2020) Andrew M. K. Law et al. Cells
- Tumor-associated macrophages
- (2020) Luca Cassetta et al. CURRENT BIOLOGY
- Metastasis-associated fibroblasts promote angiogenesis in metastasized pancreatic cancer via the CXCL8 and the CCL2 axes
- (2020) Thomas M. Pausch et al. Scientific Reports
- Chemokines and chemokine receptors: A new strategy for breast cancer therapy
- (2020) Hui Liu et al. Cancer Medicine
- CCL2 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node Stage
- (2020) Markus Eckstein et al. Cancers
- Cytokines and Chemokines as Mediators of Prostate Cancer Metastasis
- (2020) Timothy O. Adekoya et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cancer cell CCR2 orchestrates suppression of the adaptive immune response
- (2020) Miriam R. Fein et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Monocyte Chemoattractant Protein-1 promotes cancer cell migration via c-Raf/MAPK/AP-1 pathway and MMP-9 production in osteosarcoma
- (2020) Ju-Fang Liu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- CCL2 facilitates spinal synaptic transmission and pain via interaction with presynaptic CCR2 in spinal nociceptor terminals
- (2020) Sui-Bin Ma et al. Molecular Brain
- Notch3 Knockout Suppresses Mouse Mammary Gland Development and Inhibits the Proliferation of 4T1 Murine Mammary Carcinoma Cells via CCL2/CCR4 Axis
- (2020) Wei Xiong et al. Frontiers in Cell and Developmental Biology
- Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy
- (2020) Megan M. Tu et al. Communications Biology
- Loganin alleviates macrophage infiltration and activation by inhibiting the MCP-1/CCR2 axis in diabetic nephropathy
- (2020) Qiu Du et al. LIFE SCIENCES
- CCR2-Dependent Recruitment of Tregs and Monocytes Following Radiotherapy Is Associated with TNFα-Mediated Resistance
- (2019) Michele Mondini et al. Cancer Immunology Research
- MCP-1/CCL2 Mediated by Autocrine Loop of PDGF-BB Promotes Invasion of Lung Cancer Cell by Recruitment of Macrophages Via CCL2–CCR2 Axis
- (2019) Mei Ding et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- The potentials of CCL 2‐ CCR 2 blockers including propagermanium as anticancer agents
- (2019) Kanae Yumimoto et al. CANCER SCIENCE
- RS 504393 inhibits M-MDSCs recruiting in immune microenvironment of bladder cancer after gemcitabine treatment
- (2019) Xing-Yu Mu et al. MOLECULAR IMMUNOLOGY
- The Neutrophil’s Role During Health and Disease
- (2019) Pei Xiong Liew et al. PHYSIOLOGICAL REVIEWS
- Metalloproteinases and their Roles in Human Cancer
- (2019) Roopali Roy et al. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
- Phase 1b study of a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinoma
- (2019) Marcus Noel et al. INVESTIGATIONAL NEW DRUGS
- Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications
- (2019) Yuxin Lin et al. Journal of Hematology & Oncology
- ELF-1 expression in nasopharyngeal carcinoma facilitates proliferation and metastasis of cancer cells via modulation of CCL2/CCR2 signaling
- (2019) Chang-Han Chen et al. Cancer Management and Research
- CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway
- (2019) Hiroaki Yasui et al. CLINICAL & EXPERIMENTAL METASTASIS
- Klotho‐mediated targeting of CCL 2 suppresses the induction of colorectal cancer progression by stromal cell senescent microenvironments
- (2019) Yangyang Liu et al. Molecular Oncology
- Structural basis of chemokine and receptor interactions: Key regulators of leukocyte recruitment in inflammatory responses
- (2019) Ram Prasad Bhusal et al. PROTEIN SCIENCE
- Tumor-Specific Regulatory T Cells from the Bone Marrow Orchestrate Antitumor Immunity in Breast Cancer
- (2019) Yingzi Ge et al. Cancer Immunology Research
- Tumor‐associated macrophages secrete CC‐chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer
- (2019) Dongbo Li et al. CANCER SCIENCE
- CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas
- (2019) Joseph A. Flores-Toro et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally?
- (2018) Teizo Yoshimura Cellular & Molecular Immunology
- Chemokines: the past, the present and the future
- (2018) Peng Tang et al. Cellular & Molecular Immunology
- The regulation and importance of monocyte chemoattractant protein-1
- (2018) Vanessa Bianconi et al. CURRENT OPINION IN HEMATOLOGY
- A guide to chemokines and their receptors
- (2018) Catherine E. Hughes et al. FEBS Journal
- CCL2 conditionally determines CCL22-dependent Th2-accumulation during TGF-β-induced breast cancer progression
- (2018) Palash Kumar Mandal et al. IMMUNOBIOLOGY
- Implications of macrophage polarization in autoimmunity
- (2018) Samanta C. Funes et al. IMMUNOLOGY
- CCL2-SQSTM1 positive feedback loop suppresses autophagy to promote chemoresistance in gastric cancer
- (2018) Wenxia Xu et al. International Journal of Biological Sciences
- Overall survival in a trial of orally administered CCR2 inhibitor CCX872 in locally advanced/metastatic pancreatic cancer: Correlation with blood monocyte counts.
- (2018) David Linehan et al. JOURNAL OF CLINICAL ONCOLOGY
- High levels of CCL2 or CCL4 in the tumor microenvironment predict unfavorable survival in lung adenocarcinoma
- (2018) Lei Li et al. Thoracic Cancer
- PD-1/PD-L1 immune checkpoint: Potential target for cancer therapy
- (2018) Fatemeh K. Dermani et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Plasma Chemokine CCL2 and Its Receptor CCR2 Concentrations as Diagnostic Biomarkers for Breast Cancer Patients
- (2018) Emilia Lubowicka et al. Biomed Research International
- Recruitment of CCR2+ tumor associated macrophage to sites of liver metastasis confers a poor prognosis in human colorectal cancer
- (2018) Julie G Grossman et al. OncoImmunology
- Paget’s “Seed and Soil” Theory of Cancer Metastasis
- (2018) Mohammed Akhtar et al. ADVANCES IN ANATOMIC PATHOLOGY
- Role of anlotinib-induced CCL2 decrease in anti-angiogenesis and response prediction for non-small cell lung cancer therapy
- (2018) Jun Lu et al. EUROPEAN RESPIRATORY JOURNAL
- Contribution of regulatory T cells to cancer: A review
- (2018) Masoud Najafi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- T lymphocyte subsets in cancer immunity: Friends or foes
- (2018) Dounia Chraa et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Getting TANned: How the tumor microenvironment drives neutrophil recruitment
- (2018) Shuvasree SenGupta et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Therapeutic strategies involving survivin inhibition in cancer
- (2018) David Martínez‐García et al. MEDICINAL RESEARCH REVIEWS
- Turning foes to friends: targeting cancer-associated fibroblasts
- (2018) Xueman Chen et al. NATURE REVIEWS DRUG DISCOVERY
- Crystal Structure of CC Chemokine Receptor 2A in Complex with an Orthosteric Antagonist Provides Insights for the Design of Selective Antagonists
- (2018) Anna-Katharina Apel et al. STRUCTURE
- Targeting both tumour-associated CXCR2+neutrophils and CCR2+macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma
- (2017) Timothy M Nywening et al. GUT
- Structural Analysis of Chemokine Receptor–Ligand Interactions
- (2017) Marta Arimont et al. JOURNAL OF MEDICINAL CHEMISTRY
- The CCL2-CCR2 Axis in Lymph Node Metastasis From Oral Squamous Cell Carcinoma: An Immunohistochemical Study
- (2017) Shuichi Fujita et al. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- Perioperative cytokine levels portend early death after pancreatectomy for ductal adenocarcinoma
- (2017) Heather L. Lewis et al. JOURNAL OF SURGICAL ONCOLOGY
- The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2
- (2017) Torsten Hartwig et al. MOLECULAR CELL
- EMT and inflammation: inseparable actors of cancer progression
- (2017) Meggy Suarez-Carmona et al. Molecular Oncology
- CCL2 expression correlates with Snail expression and affects the prognosis of patients with gastric cancer
- (2017) Jia Zhang et al. PATHOLOGY RESEARCH AND PRACTICE
- Targeting CCR2 with its antagonist suppresses viability, motility and invasion by downregulating MMP-9 expression in non-small cell lung cancer cells
- (2017) Jun An et al. Oncotarget
- Role of tumor microenvironment in tumorigenesis
- (2017) Maonan Wang et al. Journal of Cancer
- A Natural CCR2 Antagonist Relieves Tumor-associated Macrophage-mediated Immunosuppression to Produce a Therapeutic Effect for Liver Cancer
- (2017) Wenbo Yao et al. EBioMedicine
- CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells
- (2016) Alan L. Chang et al. CANCER RESEARCH
- CCR2 Influences T Regulatory Cell Migration to Tumors and Serves as a Biomarker of Cyclophosphamide Sensitivity
- (2016) Pierre-Louis Loyher et al. CANCER RESEARCH
- FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3–CCL2 Signaling
- (2016) Xuguang Yang et al. CANCER RESEARCH
- MCP-1-induced ERK/GSK-3β/Snail signaling facilitates the epithelial–mesenchymal transition and promotes the migration of MCF-7 human breast carcinoma cells
- (2016) Shun Li et al. Cellular & Molecular Immunology
- Tumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal Adenocarcinoma
- (2016) Anusha Kalbasi et al. CLINICAL CANCER RESEARCH
- Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial
- (2016) Timothy M Nywening et al. LANCET ONCOLOGY
- Blocking the CCL2–CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model
- (2016) Kun-Yu Teng et al. MOLECULAR CANCER THERAPEUTICS
- The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
- (2016) Vinit Kumar et al. TRENDS IN IMMUNOLOGY
- High expression of C-C chemokine receptor 2 associates with poor overall survival in gastric cancer patients after surgical resection
- (2016) Ruochen Li et al. Oncotarget
- CCL2/CCR2 axis is associated with postoperative survival and recurrence of patients with non-metastatic clear-cell renal cell carcinoma
- (2016) Zewei Wang et al. Oncotarget
- Targeting the CCL2-CCR2 signaling axis in cancer metastasis
- (2016) Su Yin Lim et al. Oncotarget
- Reprogramming of Normal Fibroblasts into Cancer-Associated Fibroblasts by miRNAs-Mediated CCL2/VEGFA Signaling
- (2016) Hua Shen et al. PLoS Genetics
- CCL2 as a potential therapeutic target for clear cell renal cell carcinoma
- (2016) Ryuichiro Arakaki et al. Cancer Medicine
- Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma
- (2015) Xiaoguang Li et al. GUT
- Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages
- (2015) Stefano Ugel et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeted delivery of CCR2 antagonist to activated pulmonary endothelium prevents metastasis
- (2015) Marko Roblek et al. JOURNAL OF CONTROLLED RELEASE
- CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages
- (2015) Takanori Kitamura et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Chemokine System in Innate Immunity
- (2015) Caroline L. Sokol et al. Cold Spring Harbor Perspectives in Biology
- Serum chemokine (CC motif) ligand 2 level as a diagnostic, predictive, and prognostic biomarker for prostate cancer
- (2015) Kouji Izumi et al. Oncotarget
- CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathway
- (2015) Jing Yang et al. Oncotarget
- CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function
- (2015) Eunyoung Chun et al. Cell Reports
- Cancer metastases: challenges and opportunities
- (2015) Xiangming Guan Acta Pharmaceutica Sinica B
- Novel Markers to Delineate Murine M1 and M2 Macrophages
- (2015) Kyle A. Jablonski et al. PLoS One
- A CCL2/ROS autoregulation loop is critical for cancer-associated fibroblasts-enhanced tumor growth of oral squamous cell carcinoma
- (2014) Xia Li et al. CARCINOGENESIS
- Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
- (2014) Peter J. Murray et al. IMMUNITY
- Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
- (2014) J.-I. Youn et al. JOURNAL OF IMMUNOLOGY
- Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers
- (2014) Francois Moisan et al. Molecular Oncology
- Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis
- (2014) Laura Bonapace et al. NATURE
- New nomenclature for atypical chemokine receptors
- (2014) Françoise Bachelerie et al. NATURE IMMUNOLOGY
- Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study
- (2014) Irene Brana et al. Targeted Oncology
- The CCL2/CCR2 axis enhances IL-6-induced epithelial-mesenchymal transition by cooperatively activating STAT3-Twist signaling
- (2014) Wei Chen et al. TUMOR BIOLOGY
- Expression of monocyte chemotactic protein-1/CCL2 in gastric cancer and its relationship with tumor hypoxia
- (2014) Lei-Lei Tao WORLD JOURNAL OF GASTROENTEROLOGY
- A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors
- (2013) Shahneen K. Sandhu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
- (2013) D. E. Sanford et al. CLINICAL CANCER RESEARCH
- Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation
- (2013) Kouji Izumi et al. EMBO Molecular Medicine
- Identification of Serum Monocyte Chemoattractant Protein-1 and Prolactin as Potential Tumor Markers in Hepatocellular Carcinoma
- (2013) Who-Whong Wang et al. PLoS One
- Endothelial CCR2 Signaling Induced by Colon Carcinoma Cells Enables Extravasation via the JAK2-Stat5 and p38MAPK Pathway
- (2012) Monika Julia Wolf et al. CANCER CELL
- Primary Tumor Hypoxia Recruits CD11b+/Ly6Cmed/Ly6G+Immune Suppressor Cells and Compromises NK Cell Cytotoxicity in the Premetastatic Niche
- (2012) Jaclyn Sceneay et al. CANCER RESEARCH
- Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models
- (2012) Massimo Zollo et al. CLINICAL & EXPERIMENTAL METASTASIS
- Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer
- (2012) Kenneth J. Pienta et al. INVESTIGATIONAL NEW DRUGS
- CCL2/CCR2 Chemokine Signaling Coordinates Survival and Motility of Breast Cancer Cells through Smad3 Protein- and p42/44 Mitogen-activated Protein Kinase (MAPK)-dependent Mechanisms
- (2012) Wei Bin Fang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structural basis for high selectivity of anti-CCL2 neutralizing antibody CNTO 888
- (2012) Galina Obmolova et al. MOLECULAR IMMUNOLOGY
- CCL2 increases MMP-9 expression and cell motility in human chondrosarcoma cells via the Ras/Raf/MEK/ERK/NF-κB signaling pathway
- (2011) Chih-Hsin Tang et al. BIOCHEMICAL PHARMACOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Chemokines in tumor development and progression
- (2011) Naofumi Mukaida et al. EXPERIMENTAL CELL RESEARCH
- A MCP1 fusokine with CCR2-specific tumoricidal activity
- (2011) Moutih Rafei et al. Molecular Cancer
- CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
- (2011) Bin-Zhi Qian et al. NATURE
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Perspective on Cancer Cell Metastasis
- (2011) C. L. Chaffer et al. SCIENCE
- MCP-1: Chemoattractant with a role beyond immunity: A review
- (2010) Amita Yadav et al. CLINICA CHIMICA ACTA
- Serum CCL2 and serum TNF-α – Two new biomarkers predict bone invasion, post-treatment distant metastasis and poor overall survival in nasopharyngeal carcinoma
- (2010) Xing Lu et al. EUROPEAN JOURNAL OF CANCER
- Curcumin's Effect on Intestinal Inflammation and Tumorigenesis in the ApcMin/+ Mouse
- (2010) E. Angela Murphy et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy
- (2010) Xinmei Zhu et al. JOURNAL OF NEURO-ONCOLOGY
- The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases
- (2010) Grégory Conductier et al. JOURNAL OF NEUROIMMUNOLOGY
- Multiple Roles of Chemokine (C-C Motif) Ligand 2 in Promoting Prostate Cancer Growth
- (2010) J. Zhang et al. JNCI-Journal of the National Cancer Institute
- CCL2 Blockade Augments Cancer Immunotherapy
- (2009) Z. G. Fridlender et al. CANCER RESEARCH
- Lymphocytes in cancer development: Polarization towards pro-tumor immunity
- (2009) Brian Ruffell et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
- (2009) Satish L. Deshmane et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone
- (2008) Yi Lu et al. CLINICAL & EXPERIMENTAL METASTASIS
- CCL2 Protects Prostate Cancer PC3 Cells from Autophagic Death via Phosphatidylinositol 3-Kinase/AKT-dependent Survivin Up-regulation
- (2008) Hernan Roca et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Central Role for Tumor-derived Monocyte Chemoattractant Protein-1 in Malignant Pleural Effusion
- (2008) G. T. Stathopoulos et al. JNCI-Journal of the National Cancer Institute
- The Expression of Monocyte Chemotactic Protein-1 in Papillary Thyroid Carcinoma Is Correlated with Lymph Node Metastasis and Tumor Recurrence
- (2008) Katsuhiro Tanaka et al. THYROID
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started